IBDEI1AC ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23013,0)
 ;;=302.71^^144^1419^45
 ;;^UTILITY(U,$J,358.3,23013,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23013,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,23013,1,5,0)
 ;;=5^Decreased Libido
 ;;^UTILITY(U,$J,358.3,23013,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,23014,0)
 ;;=785.6^^144^1419^96
 ;;^UTILITY(U,$J,358.3,23014,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23014,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,23014,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,23014,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,23015,0)
 ;;=728.85^^144^1419^102
 ;;^UTILITY(U,$J,358.3,23015,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23015,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,23015,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,23015,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,23016,0)
 ;;=782.0^^144^1419^50
 ;;^UTILITY(U,$J,358.3,23016,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23016,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,23016,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,23016,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,23017,0)
 ;;=278.00^^144^1419^107
 ;;^UTILITY(U,$J,358.3,23017,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23017,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,23017,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,23017,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,23018,0)
 ;;=278.01^^144^1419^108
 ;;^UTILITY(U,$J,358.3,23018,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23018,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,23018,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,23018,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,23019,0)
 ;;=783.5^^144^1419^117
 ;;^UTILITY(U,$J,358.3,23019,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23019,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,23019,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,23019,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,23020,0)
 ;;=783.6^^144^1419^118
 ;;^UTILITY(U,$J,358.3,23020,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23020,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,23020,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,23020,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,23021,0)
 ;;=780.2^^144^1419^134
 ;;^UTILITY(U,$J,358.3,23021,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23021,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,23021,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,23021,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,23022,0)
 ;;=783.1^^144^1419^146
 ;;^UTILITY(U,$J,358.3,23022,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23022,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,23022,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,23022,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,23023,0)
 ;;=783.21^^144^1419^147
 ;;^UTILITY(U,$J,358.3,23023,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23023,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,23023,1,5,0)
 ;;=5^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,23023,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,23024,0)
 ;;=796.2^^144^1419^32
 ;;^UTILITY(U,$J,358.3,23024,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23024,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,23024,1,5,0)
 ;;=5^Blood Pressure Elevated, w/o HTN
 ;;^UTILITY(U,$J,358.3,23024,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,23025,0)
 ;;=790.92^^144^1419^9
 ;;^UTILITY(U,$J,358.3,23025,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23025,1,4,0)
 ;;=4^790.92
 ;;^UTILITY(U,$J,358.3,23025,1,5,0)
 ;;=5^Abnorm Coagulation Profile
 ;;^UTILITY(U,$J,358.3,23025,2)
 ;;=Abnorm Coagulation Profile^295771
 ;;^UTILITY(U,$J,358.3,23026,0)
 ;;=794.31^^144^1419^10
